Jaguar Animal Health, Inc. (NASDAQ: JAGX) Starts Presentation at the 2017 Marcum Microcap Conference
Jaguar Animal Health (NASDAQ: JAGX) is an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals, and high value horses. Canalevia™ is Jaguar’s lead prescription drug product candidate, intended for the treatment of various forms of diarrhea in dogs. Equilevia™ is Jaguar’s prescription drug product candidate for the treatment of gastrointestinal ulcers in horses. Jaguar has nine active investigational new animal drug applications, or INADs, filed with the FDA. For more information, visit the company's website at jaguaranimalhealth.com About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides to users (1) access…







